Paolo Morgese

Paolo Morgese leads European public affairs activities at the Alliance for Regenerative Medicine (ARM). He is a patient access, healthcare policy and investment professional with more than 20 years of experience in both assessing and supporting access to innovative healthcare technologies. Before joining ARM in 2017, Paolo worked for 5 years at Deerfield Management, a healthcare investment company. Prior to that, he worked at Merck Serono, Kyphon (which became Medtronic) and also spent several years with the Italian Health Technology Assessment Agency Agenas. Paolo’s interests and expertise are centered on cell and gene therapy value assessment, healthcare system modernization and financing healthcare innovation.